|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2862929 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14195359.6 |
| Europos patento paraiškos padavimo data | 2010-12-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 267835 P | 2009-12-09 | US | |
| 319894 P | 2010-04-01 | US |
| (72) |
Feinstein, Elena, IL
Spivak, Igor, IL
Alpert, Evgenia, IL
Lahav, Ron, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | Compositions and methods for treating diseases, disorders or injury of the CNS |
| Compositions and methods for treating diseases, disorders or injury of the CNS |